JP2006089487A5 - - Google Patents

Download PDF

Info

Publication number
JP2006089487A5
JP2006089487A5 JP2005290190A JP2005290190A JP2006089487A5 JP 2006089487 A5 JP2006089487 A5 JP 2006089487A5 JP 2005290190 A JP2005290190 A JP 2005290190A JP 2005290190 A JP2005290190 A JP 2005290190A JP 2006089487 A5 JP2006089487 A5 JP 2006089487A5
Authority
JP
Japan
Prior art keywords
citrulline
active ingredient
antioxidant
active
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005290190A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006089487A (ja
JP4691658B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2005290190A priority Critical patent/JP4691658B2/ja
Priority claimed from JP2005290190A external-priority patent/JP4691658B2/ja
Publication of JP2006089487A publication Critical patent/JP2006089487A/ja
Publication of JP2006089487A5 publication Critical patent/JP2006089487A5/ja
Application granted granted Critical
Publication of JP4691658B2 publication Critical patent/JP4691658B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2005290190A 2005-10-03 2005-10-03 抗酸化食品添加物 Expired - Fee Related JP4691658B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005290190A JP4691658B2 (ja) 2005-10-03 2005-10-03 抗酸化食品添加物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005290190A JP4691658B2 (ja) 2005-10-03 2005-10-03 抗酸化食品添加物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2001027772A Division JP3843298B2 (ja) 2001-02-05 2001-02-05 シトルリンを含有する活性酸素消去剤

Publications (3)

Publication Number Publication Date
JP2006089487A JP2006089487A (ja) 2006-04-06
JP2006089487A5 true JP2006089487A5 (de) 2006-07-20
JP4691658B2 JP4691658B2 (ja) 2011-06-01

Family

ID=36230788

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005290190A Expired - Fee Related JP4691658B2 (ja) 2005-10-03 2005-10-03 抗酸化食品添加物

Country Status (1)

Country Link
JP (1) JP4691658B2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008105384A1 (ja) * 2007-02-26 2008-09-04 Kyowa Hakko Bio Co., Ltd. シトルリン含有錠剤
JP5288788B2 (ja) * 2007-12-28 2013-09-11 三菱鉛筆株式会社 水性インキ組成物
JP2014045683A (ja) * 2012-08-30 2014-03-17 Fuji Oil Co Ltd 食用油脂及びそれを含有する食品並びにその製造方法
JP2014118405A (ja) * 2012-12-19 2014-06-30 Kose Corp Ｄｎａ損傷抑制剤
JP2014129267A (ja) * 2012-12-28 2014-07-10 Kose Corp Ｄｎａ損傷抑制剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3561920D1 (en) * 1984-09-12 1988-04-28 Firmenich & Cie Process for improving or modifying the taste and aroma of citrus fruit compositions
DE4341000A1 (de) * 1993-12-02 1995-06-08 Beiersdorf Ag Verwendung von L-Arginin, L-Ornithin oder L-Citrullin und topischen Zubereitungen mit diesen Stoffen
JPH09241637A (ja) * 1996-03-14 1997-09-16 Chugai Pharmaceut Co Ltd 活性酸素ラジカル除去用組成物およびその方法
US6028107A (en) * 1997-02-27 2000-02-22 Waugh; William Howard Orthomolecular medical use of L-citrulline for vasoprotection, relaxative smooth muscle tone and cell protection

Similar Documents

Publication Publication Date Title
AU2007299727A8 (en) Self preserved aqueous pharmaceutical compositions
AP2405A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms.
WO2007146965A3 (en) Compounds for the treatment of periodontal disease
WO2006091529A3 (en) A solid pharmaceutical dosage formulation
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
WO2009137391A3 (en) Benzene sulfonamide thiazole and oxazole compounds
WO2008006528A3 (en) Pharmaceutical compositions comprising levetiracetam
ZA200902632B (en) Haloalkylsufonanilide derivative or salt thereof, herbicide comprising the derivative as active ingredient, and use of the herbicide
EP2607348A3 (de) Hemmer des plasminogen-aktivator-inhibitors 1
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
EP2045253A4 (de) alpha-AMINOSÄUREDERIVAT UND PHARMAZEUTIKUM, DAS DIESES ALS WIRKSTOFF ENTHÄLT
CL2007003265A1 (es) Compuestos derivados de 1h-piran[2,3-d]pirimidin-2,4,7-triona; y composicion farmaceutica, util para el tratamiento de sindrome metabolico, dislipidemia y enfermedades cardiovasculares entre otras.
EP2078731A4 (de) Anti-hb-egf-antikörper als wirkstoff enthaltende pharmazeutische zusammensetzung
DK1932522T3 (da) Terapeutisk middel mod leversygdom indeholdende 2-amino-1,3-propandiolderivat som aktiv bestanddel
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
WO2007009720A3 (en) Prodrugs of pyrazoline compounds, their preparation and use as medicaments
WO2010021607A3 (en) Pharmaceutical formulation
WO2007009721A3 (en) Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments
WO2007009701A3 (en) Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome
WO2006056696A3 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
IL185197A0 (en) Ophthalmological pharmaceutical compositions
IL191758A0 (en) Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof
ITRM20050179A1 (it) Composizione impiegabile per il trattamento delle patologie paradontali.
JP2006089487A5 (de)
WO2007009686A3 (en) Substituted pyrazoline compounds, their preparation and use as medicaments